Do Sleep Supplements Work for College Students?
Last updated July 17, 2026 · By Dave Knoepfle · About
We were going to sell you one.
Not hypothetically. We had a finished formula — four ingredients, each selected against a rule we wrote down before we started looking: define the outcome and the instrument first, find human randomized trials on that exact endpoint in stressed adults at a matching dose, and only then ask about mechanism. Anything that failed step two didn’t go in. That rule killed about twenty ingredients before it killed the product.
Then we killed the product.
This is what we found on the way. We have nothing to sell you in this category — that’s the only reason this page is worth reading.
Key takeaways
- Melatonin buys you about seven minutes. In the largest meta-analysis, it cut time-to-sleep by 7.06 minutes and added 8.25 minutes of total sleep.
- But melatonin is a clock drug, not a sleep drug — and that distinction is the most useful thing on this page for a college student.
- Magnesium: five randomized trials exist, totalling 247 people. The famous “magnesium deepens sleep” finding is twelve of them, for two weeks, in a study its own reviewers say “cannot be applied to an adult population.”
- Glycine: roughly 33 people, three trials, all traceable to a single manufacturer.
- One ingredient has real evidence — six trials, a genuine meta-analysis, EEG data, in exactly the right population. The meta-analysis was paid for by the company that sells it.
- That’s the pattern. The analysis is sometimes independent. The data almost never is.
Did you know?
Across 19 studies and 1,683 people, melatonin reduced the time it takes to fall asleep by 7.06 minutes and increased total sleep by 8.25 minutes. The authors called the effects “modest,” and noted they were smaller than for prescription sleep medications.
Source: Ferracioli-Oda et al., PLOS One, 2013.
Melatonin: seven minutes — and the thing nobody tells you
Melatonin is the default. It’s the thing in the dorm drawer, the thing the roommate recommends, the thing a parent buys in a gas station on move-in weekend.
The largest meta-analysis pooled 19 studies and 1,683 subjects. Melatonin reduced sleep latency by 7.06 minutes (95% CI 4.37–9.75) and increased total sleep time by 8.25 minutes. Sleep quality improved with a standardized effect size of 0.22 — small, by any convention. The authors’ own summary: the effects are modest, and smaller in absolute terms than benzodiazepines or the newer sleep medications.
Seven minutes.
But here’s the part that actually matters, and almost nobody says it.
A different meta-analysis split the results by what was wrong with the person. In people with insomnia, melatonin cut sleep latency by 7.2 minutes — the same unimpressive number. In people with delayed sleep phase syndrome, it cut it by 38.8 minutes. The authors flagged that second result as clinically important. The first one, they didn’t.
Melatonin isn’t a sleep drug. It’s a clock drug. It works when the problem is that your body thinks it’s the wrong time of day. It barely works when the problem is that you can’t sleep.
Now: what does a college student have?
A student who’s up at 2am and dead at 8am doesn’t have insomnia. She has a delayed clock — the most extensively documented sleep phenomenon in this entire population. Which means melatonin might be the one supplement that’s genuinely aimed at her problem.
She’s just taking it for the wrong reason, at the wrong time, in the wrong dose, expecting the wrong thing. She takes it to sleep better. It doesn’t do that. It moves the schedule.
That’s not a small correction. That’s the difference between a thing that works and a thing that doesn’t.
Magnesium: twelve people
Magnesium is having a moment. It also has, in the entire published literature, five randomized trials. Ever. A 2023 systematic review by Arab and colleagues found all of them. Here they are, in full:
| Trial | People | What it found | Their quality rating |
|---|---|---|---|
| Nielsen 2010 (USA) | 100 | 320 mg/day, 7 weeks | Low |
| Frusso 1999 (Argentina) | 45 | Nothing — and it was a leg-cramp study | Fair |
| Liu 2015 (USA) | 44 | Nothing | Fair |
| Held 2002 (Germany) | 12 | More slow-wave sleep | Low |
| Abbasi 2012 (Iran) | 46 | More sleep time, better efficiency, faster onset | High |
That’s 247 people. All of them. That is the complete randomized evidence base for one of the best-selling sleep supplements in America.
Look at the fourth row.
Held 2002 is the study behind “magnesium increases deep sleep.” It’s the one the mechanism rests on — the slow-wave finding, the delta power, the reason magnesium gets called restorative rather than sedating.
It is twelve people, for two weeks.
And you don’t have to take my word that it doesn’t hold. Take the reviewers’. In their own assessment: a study of fewer than 20 subjects “is unlikely to be sufficient for investigation,” and the results “cannot be applied to an adult population.” They rated it low quality and published it anyway, because there was nothing better to include.
Then Mah and Pitre pooled the three trials in older adults — 151 people — and found magnesium cut time-to-sleep by 17.36 minutes (95% CI −27.27 to −7.44, p = 0.0006). Then they graded every trial at moderate-to-high risk of bias, rated the evidence “low to very low,” and concluded that the quality of the literature is substandard for physicians to make recommendations.
That’s not me characterizing the field. That’s two independent review teams, funded by universities rather than manufacturers, saying it in print.
Glycine: thirty-three people, one company
This is the one that taught us the most, and it isn’t because glycine is bad.
The glycine sleep story is genuinely appealing: a coherent mechanism, consistent positive results, and an unusual benefit — better morning alertness rather than sedation. Three trials, all at 3 grams before bed, all positive.
All three trace back to scientists affiliated with Ajinomoto — the Japanese amino acid manufacturer that sells glycine. Total participants across all three: roughly 33 people.
That’s not fraud. The findings are internally consistent, the mechanism is plausible, and glycine is cheap and safe. But “consistent across three studies by one company” is a different claim from “replicated.” One of those tells you the effect is real. The other tells you the company can reproduce its own result.
Thirty-three people, one sponsor, twenty years.
The pattern is the finding
We went in expecting to sort the shelf into things that work and things that don’t.
That isn’t the shape of the problem. The shape of the problem is that almost nobody is funding sleep supplement research except the people selling sleep supplements.
The analysis is sometimes independent — you’ll find a meta-analysis run by a university group or a contract research outfit with no product to sell. The underlying data almost never is. And a meta-analysis of six sponsor-funded trials is a very well-organized way of asking the sponsor the same question six times.
Once you see it, you can’t unsee it. It’s not a scandal. It’s just the economics: nobody gets a research grant to find out whether magnesium helps you sleep.
The one with real evidence — and the asterisk
Now the honest part, because there is one ingredient that’s better than everything above.
Lactobacillus gasseri CP2305 is a heat-inactivated bacterial strain — technically a “paraprobiotic,” since it isn’t alive. It was the anchor of our formula and it’s the only ingredient we found whose research population was defined by being stressed, rather than being 45-year-old insomniacs.
The evidence:
- A systematic review found seven studies; six had data poolable for meta-analysis.
- Pooled effect on the Pittsburgh Sleep Quality Index: −0.77 (95% CI −1.37 to −0.16, p = 0.01) versus control.
- Two studies included EEG. In both, at least half the measured EEG outcomes improved. One found the tablet shortened time to reach deep N3 sleep, cut wake-after-sleep-onset, and increased delta power in the first non-REM cycle.
- The trial populations were medical students — 32 during a cadaver dissection course, 74 preparing for national licensure exams. Real people under real academic stress.
- The reviewers found no serious concerns about bias, indirectness, or methodology.
That is, by a distance, the strongest evidence in this category. Now the two things that go with it.
The effect is small. The PSQI runs 0 to 21. A difference of 0.77 points is statistically real and clinically modest. It is not the difference between a bad semester and a good one.
And the meta-analysis was funded by the manufacturer. In its own words: the systematic review was funded by Asahi Group Holdings Ltd, as payment to the research group that conducted it — Edible Research Ltd. The trials themselves used product supplied by Asahi Calpis Wellness. Every one of the seven studies was conducted in Japan.
To be fair, and this matters: the review states that Asahi had no scientific input into the design, processing or interpretation of the results. That’s a real firewall, disclosed properly, and it’s to the reviewers’ credit — it’s also the only reason we can tell you any of this.
But look at what the firewall protects and what it doesn’t. The analysis was independent. The data wasn’t. Six trials, one sponsor, one country. You can hire the most scrupulous statisticians alive and it doesn’t change what happens upstream of them — and asking a careful outsider to analyze six studies you paid for is not the same as six labs finding the same thing.
That’s the whole essay in one ingredient. The best evidence available in this category is independently analyzed, internally generated, and modest.
So why did we kill ours?
Not because the formula was bad. It was defensible — four ingredients, each the best-evidenced option in its lane, each surviving a rule that eliminated most of the shelf.
We killed it because we asked a different question. Not what could we sell a parent but what would actually change a student’s sleep this semester.
And the answer was embarrassing. She doesn’t know her Diet Coke has caffeine. She doesn’t know that sleeping badly five nights a week turns a 3.6 into a 3.5. She doesn’t know that the good night before the exam does nothing, and it’s the month before that counts. She doesn’t know that being awake 22 hours is the impairment of the legal drinking limit.
No capsule fixes any of that. Not ours. Not the best one on the shelf.
We had a product that might have been worth 0.77 PSQI points, and a student who’d never been told a single true thing about her own sleep. So we stopped making the capsule.
What nobody tells college students about sleep
College Wrecks Your Sleep is 30 things your student doesn’t know about sleep, delivered one at a time over six weeks. Not a program to follow. Not a routine to maintain. Just the facts nobody gave them.
What the evidence actually says
| The evidence | The honest read | |
|---|---|---|
| Melatonin | −7.06 min to sleep, +8.25 min total, quality SMD 0.22 (19 studies, n=1,683). But −38.8 min in delayed sleep phase vs −7.2 in insomnia | A clock drug, not a sleep drug. Possibly right for a phase-delayed student — for reasons she doesn’t know |
| Magnesium | 5 RCTs in existence, 247 people total. Pooled: 151 people, −17.36 min (p=0.0006), evidence graded low to very low. The slow-wave finding is n=12 | Two independent reviews call the literature substandard |
| Glycine | 3 trials, ~33 people, all Ajinomoto-affiliated | Plausible, consistent, unreplicated by anyone independent in 20 years |
| L. gasseri CP2305 | 6 trials pooled, PSQI −0.77 (p=0.01), EEG improved in both studies measuring it, stressed-student populations | Best evidence in the category. Meta-analysis funded by the manufacturer. Effect is small |
Frequently asked questions
Do sleep supplements work for college students?
Mostly not in the way they’re marketed. Melatonin reduces time-to-sleep by about 7 minutes on average (Ferracioli-Oda et al., 2013). Magnesium’s pooled randomized evidence is 151 people, and the meta-analysis grades its own evidence base “low to very low.” The best-evidenced single ingredient, L. gasseri CP2305, produced a 0.77-point improvement on a 21-point sleep quality scale. These are real effects, and they are small.
Does melatonin actually work?
For the right problem, yes. Melatonin cut sleep latency by 38.8 minutes in people with delayed sleep phase syndrome — a clinically important result — but only 7.2 minutes in people with insomnia. It shifts your body clock; it doesn’t sedate you. Most college students have a delayed clock, which means melatonin is aimed at their actual problem, but they’re generally taking it as a sleeping pill rather than as a timing signal.
Does melatonin improve deep sleep?
The evidence for improving sleep architecture is not what the marketing implies. The measured effects across meta-analyses are on sleep latency, total sleep time, and subjective quality (SMD 0.22) — modest across the board.
Is magnesium good for sleep?
The honest answer is that we don’t know yet, and the reason is that almost nobody has checked. Five randomized trials of magnesium and sleep exist in the published literature, totalling 247 participants (Arab et al., 2023). The largest is 100 people; the study behind the well-known claim that magnesium deepens slow-wave sleep is 12 people over two weeks, which its own reviewers said “cannot be applied to an adult population.” A meta-analysis pooling the three trials in older adults found a 17.36-minute reduction in time-to-sleep, then rated the evidence “low to very low” and called the literature substandard for making recommendations (Mah & Pitre, 2021).
What’s the best-evidenced sleep supplement?
By volume and quality of trial evidence, Lactobacillus gasseri CP2305 — six trials pooled in a meta-analysis, a significant PSQI improvement (−0.77, p=0.01), and EEG confirmation in the two studies that measured it, in stressed student populations. The caveat is essential: the systematic review was funded by Asahi Group Holdings, the company that sells the strain, and the effect size is small.
Why don’t independent researchers study sleep supplements?
Because nobody funds it. Supplement research is overwhelmingly paid for by supplement manufacturers, which is the economics of the category rather than a conspiracy. It means most of what you can read about a given ingredient was commissioned by someone with a product to sell.
Why did you stop selling a sleep supplement?
Because the honest ceiling on the best ingredient we could find was modest, and the students we were building for had never been told a single accurate thing about their own sleep. Information was the bigger lever. It’s the only thing we sell now.
Related reading:
- Why Doesn’t Standard Sleep Advice Work in College? — the four tips everyone gives, and why they fail
- How Does Sleep Affect College Grades and Friendships? — what the research says it costs
- Gut Health and Sleep — the gut-brain axis, without the supplement pitch
Sources:
- Ferracioli-Oda, E., Qawasmi, A. & Bloch, M.H. (2013). Meta-analysis: melatonin for the treatment of primary sleep disorders. PLOS One, 8(5), e63773.
- Buscemi, N., Vandermeer, B., Hooton, N., et al. (2005). The efficacy and safety of exogenous melatonin for primary sleep disorders: a meta-analysis. Journal of General Internal Medicine, 20(12), 1151–1158.
- Arab, A., Rafie, N., Amani, R. & Shirani, F. (2023). The role of magnesium in sleep health: a systematic review of available literature. Biological Trace Element Research, 201(1), 121–128. doi:10.1007/s12011-022-03162-1. PMID 35184264.
- Mah, J. & Pitre, T. (2021). Oral magnesium supplementation for insomnia in older adults: a systematic review & meta-analysis. BMC Complementary Medicine and Therapies, 21(1), 125. doi:10.1186/s12906-021-03297-z. PMID 33865376.
- Chu, A., Samman, S., Galland, B. & Foster, M. (2023). Daily consumption of Lactobacillus gasseri CP2305 improves quality of sleep in adults — a systematic literature review and meta-analysis. Clinical Nutrition, 42(8), 1314–1321. doi:10.1016/j.clnu.2023.06.019.
- Nishida, K., Sawada, D., Kuwano, Y., et al. (2019). Health benefits of Lactobacillus gasseri CP2305 tablets in young adults exposed to chronic stress: a randomized, double-blind, placebo-controlled study. Nutrients, 11(8), 1859. doi:10.3390/nu11081859.
- Nishida, K., Sawada, D., Kawai, T., et al. (2017). Para-psychobiotic Lactobacillus gasseri CP2305 ameliorates stress-related symptoms and sleep quality. Journal of Applied Microbiology, 123(6), 1561–1570. PMID 28948675.
- Yamadera, W., Inagawa, K., Chiba, S., et al. (2007). Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep and Biological Rhythms, 5(2), 126–131.